Trugman J, Finnegan M, Lipton R, et al. Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results from a Single Attack Phase II Study, ACHIEVE I. AAN 2018, emerging science abstract 008.
Biomarkermodel voorspelt risico op dementie bij milde cognitieve stoornissen
okt 2019 | Dementie